Table 4.
GIB severity among patients suffering GIB according to PPIs use before and after PSM.
| GIB Severity | Before PSM | After PSM | |||||
|
PPIs
(n = 261) |
No PPIs
(n = 20) |
P |
PPIs
(n = 107) |
No PPIs
(n = 20) |
P | ||
| Data are presented as n (%). GIB: gastrointestinal bleeding; Hb: hemoglobin; NA: not assessed; PSM: propensity score matching; PPIs: proton pump inhibitors. | |||||||
| Hb reduction | 0.7941 | 0.6455 | |||||
| No | 86 (33.0%) | 5 (25.0%) | 40 (37.4%) | 5 (25%) | |||
| < 3 g/L | 105 (40.2%) | 8 (40.0%) | 40 (37.4%) | 8 (40.0%) | |||
| 3-5 g/L | 33 (12.6%) | 3 (15.0%) | 13 (12.1%) | 3 (15.0%) | |||
| > 5 g/L | 37 (14.2%) | 4 (20.0%) | 14 (13.1%) | 4 (20.0%) | |||
| Treatment | 0.6190 | 0.6513 | |||||
| None | 78 (29.8%) | 4 (20.0%) | 31 (28.7%) | 4 (20.0%) | |||
| Endoscopic hemostasis | 2 (0.8%) | 0 (0%) | NA | NA | |||
| Pharmacologic hemostasis | 182 (69.5%) | 16 (80%) | 76 (70.4%) | 16 (80.0%) | |||
| Blood Transfusion | 64 (24.5%) | 7 (35.0%) | 0.3146 | 24 (22.4%) | 7 (35.0%) | 0.2602 | |
| Death caused by GIB | 4 (1.5%) | 1 (5.0%) | 0.3096 | 0 (0.0%) | 1 (5.0%) | 0.1562 | |